Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment

Herken, H; Akyol, O; Yilmaz, HR; Tutkun, H; Savas, HA; Ozen, ME; Kalenderoglu, A; Gulec, MUKADDES

doi:10.1002/hup.742

Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment

Atıf İçin Kopyala

Herken H., Akyol O., Yilmaz H., Tutkun H., Savas H., Ozen M., ...Daha Fazla

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.21, sa.1, ss.53-59, 2006 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 1
Basım Tarihi: 2006
Doi Numarası: 10.1002/hup.742
Dergi Adı: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.53-59
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective In the present study, we aimed to investigate whether nitric oxide (NO) levels and activities of xanthine oxidase (XO), superoxide dismutase (SOD), and adenosine deaminase (ADA) are associated with Panic disorder (PD) as well as impact of psychopharmacological treatments on NO, SOD, ADA, and XO levels in PD.